---
filename: electrolyte-emergencies-hyperkalemia-hyponatremia.md
id: electrolyte-emergencies-hyperkalemia-hyponatremia
title: Electrolyte Emergencies (Hyperkalemia/Hyponatremia)
slug: electrolyte-emergencies-hyperkalemia-hyponatremia
tags: [electrolytes, inpatient, night-float, hyperkalemia, hyponatremia]
level: resident
estimated_time_min: 20
version: 2026-02-20
source: IM_NightFloat_Engine
---

# Electrolyte Emergencies (Hyperkalemia/Hyponatremia)

## Panic Card
- Hyperkalemia with ECG changes or **K⁺ ≥6.5 mmol/L**: place on monitor, obtain ECG, give **calcium gluconate 10% 1 g IV over 5–10 min** (or **calcium chloride 1 g IV** via central line) and repeat if ECG not improving; then shift K⁺ with **regular insulin 10 units IV + dextrose 25 g**, add **nebulized albuterol 10–20 mg**, consider **sodium bicarbonate** if severe acidemia; arrange removal (loop diuretic, binder, or dialysis). citeturn2search24turn2search19
- Severe symptomatic hyponatremia (seizure, coma, active vomiting with obtundation): give **3% NaCl 100–150 mL IV over 10–20 min**, reassess, and repeat up to two more times aiming **+4–6 mmol/L** initial rise; check Na⁺ **q2–4 h**. citeturn2search18turn2search49
- Enforce correction limits: **Na⁺ rise ≤8–10 mmol/L per 24 h** (≤4–6 if high risk: malnutrition, alcoholism, liver disease, hypokalemia). Use **desmopressin (DDAVP) 2–4 μg IV** to “clamp” if rapid aquaresis emerges. citeturn2search51turn2search44
- If refractory hyperkalemia or life‑threatening arrhythmias: call nephrology for **urgent dialysis**. citeturn2search19
- Confirm Before Proceed: Before initiating vasopressin antagonists or ongoing hypertonic therapy, verify etiology/tonicity and chronicity to avoid **osmotic demyelination** or worsening hypovolemia. citeturn2search18

## Brief Overview
- Night-float priorities: distinguish immediately dangerous **hyperkalemia** (ECG changes, **K⁺ ≥6.5**) from milder cases; for **hyponatremia**, triage by symptom severity and chronicity (acute ≤48 h vs chronic) and treat symptomatic cases with hypertonic saline boluses. citeturn2search24turn2search18
- **Guideline Must‑Know:** Hyperkalemia sequence = membrane stabilization (IV calcium) → intracellular shift (insulin/dextrose ± β₂‑agonist ± bicarbonate if acidemic) → removal (diuretics, potassium binders, or dialysis). Dialysis is definitive when refractory or with renal failure. citeturn2search19
- **Guideline Must‑Know:** UK Kidney Association 2023 update and prior Renal Association guidance endorse IV calcium for ECG changes or severe K⁺, insulin–glucose therapy with close hypoglycemia monitoring for at least **6 h**, and increasing use of modern binders (sodium zirconium cyclosilicate) over calcium polystyrene sulfonate. citeturn2search7turn2search8
- **Guideline Must‑Know:** For severe symptomatic hyponatremia, European 2014 guideline endorses **3% NaCl 100–150 mL** boluses repeated up to 3 times to achieve rapid 4–6 mmol/L rise and symptom relief. Continuous infusions are slower and risk overcorrection without strict protocols. citeturn2search38turn2search49
- **Guideline Must‑Know:** Maintain **daily Na⁺ correction ≤8–10 mmol/L** (≤4–6 if high risk) to prevent osmotic demyelination; consider **DDAVP clamp** (scheduled desmopressin with controlled hypertonic dosing) in high‑risk or rapidly autocorrecting patients. citeturn2search51turn2search46
- **Guideline Must‑Know:** Diagnostic first steps in hyponatremia: confirm hypotonicity (serum osmolality), then urine osmolality and urine Na⁺ to classify water intake vs ADH‑mediated causes; avoid early reliance on clinical volume assessment alone. citeturn2search17
- **Guideline Must‑Know:** Severe symptoms (seizure/coma), **Na⁺ <120 mmol/L** with deterioration, or failure to respond to initial boluses warrant ICU level monitoring and frequent labs **q2–4 h**. citeturn2search38
- **Guideline Must‑Know:** In hyperkalemia, modern binders (e.g., **sodium zirconium cyclosilicate 10 g TID ×48 h**) can reduce emergency dialysis needs and are endorsed by NICE for emergency use alongside standard care; onset is within hours (not minutes), so use adjunctive shifting first. citeturn2search30turn2search25turn2search26
- What must happen now (hyperkalemia): monitor on telemetry, repeat ECG after calcium; give insulin–dextrose (with preemptive dextrose infusion if glucose <7 mmol/L) and β₂‑agonist; start binder if available; identify causes (AKI, RAASi, acidosis); plan removal strategy—loop diuretics if urine output, dialysis if ESRD/refractory. citeturn2search8turn2search24
- What can wait (hyperkalemia): chronic medication reconciliation, diet counseling, long‑term RAASi strategy, outpatient binder titration. citeturn2search23
- What must happen now (hyponatremia): in severe/moderate symptoms, give **3% NaCl bolus** and reassess neurologic status and Na⁺; start DDAVP if brisk diuresis or high‑risk for overcorrection; halt hypotonic fluids and offending drugs. citeturn2search18turn2search51
- What can wait (hyponatremia): definitive SIAD therapy (fluid restriction, urea, salt + loop, cautious vaptan in select euvolemic cases after stabilization), endocrine workup (TSH, cortisol) after initial safety. citeturn2search18
- Pitfalls: missing pseudohyperkalemia (hemolysis, thrombocytosis/leukocytosis), treating transcellular shifts without addressing decreased excretion, under‑monitoring for post‑insulin hypoglycemia, and overcorrecting chronic hyponatremia after volume repletion (autocorrection). citeturn2search24turn2search8turn2search51
- Call ICU/nephrology early for hyperkalemia with arrhythmias, **K⁺ ≥6.5**, or rising despite therapy; call ICU for hyponatremia with seizures, impending respiratory compromise, or need for continuous hypertonic/DDAVP titration. citeturn2search24turn2search38
- Confirm Before Proceed: Avoid **tolvaptan** in hypovolemic hyponatremia or severe symptoms requiring hypertonic saline; avoid rapid normalizing targets—aim for **initial +4–6 mmol/L** then slow. citeturn2search38

## Top ICU/Consult Triggers
- Hyperkalemia with **ECG changes**, **K⁺ ≥6.5 mmol/L**, or ventricular arrhythmia despite initial therapy. citeturn2search24
- Hyponatremia with **seizure, coma, or rapidly worsening mental status** or need for repeated 3% NaCl boluses and DDAVP clamp. citeturn2search38
- Refractory hyperkalemia in **AKI/ESRD** or recurrence after shifts, requiring **urgent dialysis**. citeturn2search19
- Anticipated overcorrection risk (malnutrition, alcoholism, advanced liver disease, hypokalemia) necessitating **q2–4 h** labs and strict correction targets. citeturn2search51

## Orders to Place Now
- Order: Cardiac monitoring and 12‑lead ECG — {now; repeat after calcium and with any rhythm change} citeturn2search24
- Order: Calcium gluconate 10% IV — {1 g IV over 5–10 min; may repeat in 5–10 min if ECG changes persist} citeturn2search24
- Order: Regular insulin IV with dextrose — {10 units IV + 25 g dextrose; check capillary glucose q30–60 min × 6 h; start D10 if glucose <7 mmol/L} citeturn2search8
- Order: 3% sodium chloride bolus — {100–150 mL IV over 10–20 min; reassess neuro status/Na⁺; may repeat ×2} citeturn2search38turn2search49
- Order: Desmopressin (DDAVP) IV — {2–4 μg IV now if rapid aquaresis/high ODS risk; consider scheduled q6–8 h “clamp” with Na⁺ checks q2–4 h} citeturn2search51turn2search46
- Order: Potassium binder (sodium zirconium cyclosilicate) — {10 g PO now, then 10 g TID ×48 h alongside standard care} citeturn2search30

## ABIM‑Style Question 1

### Stem
A 72‑year‑old man with CKD4 presents with weakness. Vitals are stable. ECG shows peaked T waves with QRS widening. Labs: K⁺ 6.9 mmol/L, bicarbonate 18 mmol/L, creatinine 3.1 mg/dL. 

### Options
A. Furosemide 40 mg IV and repeat potassium in 6 hours  
B. Calcium gluconate 10% 1 g IV now  
C. Sodium polystyrene sulfonate 30 g PO now  
D. Regular insulin 10 units IV with 25 g dextrose, no calcium  
E. Emergent hemodialysis only

### Correct answer
B

### Rationale
IV calcium immediately stabilizes the myocardium in hyperkalemia with ECG changes; give **calcium gluconate 1 g IV** (or **calcium chloride via central line**) and reassess ECG, then proceed with insulin/dextrose and removal strategies. Deferring calcium risks malignant arrhythmia; dialysis may be needed but not as the first step when calcium can rapidly stabilize. citeturn2search24turn2search19

## Second ABIM‑Style Case (Pitfall Variant)

### Stem
A 58‑year‑old woman with severe alcoholism and malnutrition is admitted with confusion and falls. Na⁺ is 112 mmol/L, serum osmolality 250 mOsm/kg, urine osmolality 600 mOsm/kg, urine Na⁺ 45 mmol/L. After 1 L isotonic saline for presumed hypovolemia, she becomes more alert and develops brisk diuresis (urine output 300 mL/h); Na⁺ rises from 112 to 118 mmol/L in 4 hours.

### Options
A. Continue isotonic saline at current rate  
B. Start 3% saline infusion targeting +12 mmol/L in 24 hours  
C. Administer desmopressin 2 μg IV now and give 3% NaCl bolus to cap correction  
D. Start tolvaptan 15 mg PO  
E. No action; observe as Na⁺ is improving

### Correct answer
C

### Rationale
High ODS risk (alcoholism, malnutrition) mandates **≤4–6 mmol/L** daily correction. Rapid aquaresis after volume repletion risks overcorrection; a **DDAVP clamp** plus controlled hypertonic bolus caps the rise and treats symptoms safely. Vaptans are contraindicated in severe symptomatic hyponatremia and hypovolemia. citeturn2search51turn2search46turn2search38

What changed the decision here?

## Check‑Yourself Micro‑Questions
- Q: Maximum safe daily Na⁺ correction in typical adults vs high‑risk patients?  
  A: **≤8–10 mmol/L per 24 h** (typical); **≤4–6 mmol/L per 24 h** if alcoholism, malnutrition, liver disease, or hypokalemia. citeturn2search51
- Q: First drug for hyperkalemia with ECG changes?  
  A: IV calcium (gluconate 1 g or chloride 1 g via central line) to stabilize myocardium before shifting/removal therapies. citeturn2search24
- Q: Insulin/dextrose regimen effect and monitoring?  
  A: 10 units regular insulin IV + 25 g dextrose lowers K⁺ within 15–30 min; monitor glucose **q30–60 min for ~6 h** to prevent hypoglycemia. citeturn2search8
- Q: Initial hypertonic saline approach for seizures from hyponatremia?  
  A: **3% NaCl 100–150 mL IV over 10–20 min**, repeat up to ×3 aiming +4–6 mmol/L. citeturn2search38turn2search49

## Guidelines & Key References
- European Society of Endocrinology/ESICM/ERA‑EDTA. Clinical practice guideline on diagnosis and treatment of hyponatraemia, 2014. https://link.springer.com/content/pdf/10.1007/s00134-014-3210-2.pdf citeturn2search37
- AJKD Perspective: Hypertonic Saline for Hyponatremia—Meeting Goals and Avoiding Harm, 2022. https://www.ajkd.org/article/S0272-6386(21)00838-6/fulltext citeturn2search51
- KDIGO Acute Hyperkalemia in the Emergency Department (Consensus Report), 2020. https://kdigo.org/wp-content/uploads/2018/04/KDIGO-Acute-Hyperkalemia-conf-report-FINAL.pdf citeturn2search19
- UK Kidney Association Clinical Practice Guideline—Management of Hyperkalaemia in Adults, 2023 update. https://ukkidney.org/sites/default/files/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20191223_0.pdf citeturn2search7
- NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia (updated 2022). https://www.nice.org.uk/guidance/ta599/resources/sodium-zirconium-cyclosilicate-for-treating-hyperkalaemia-pdf-82607272135621 citeturn2search29

## CDI: What to Document Clearly Tonight
- Hyperkalemia, life‑threatening due to {AKI/ESRD/RAAS inhibitor}; ECG changes present; K⁺ **{value} mmol/L**; treatments given (IV calcium, insulin/dextrose, β₂‑agonist, binder/dialysis); response on repeat ECG/labs.
- Hyponatremia, {acute vs chronic} with {severe/moderate} symptoms due to {SIADH/hypovolemia/hypervolemia}; Na⁺ **{value} mmol/L**, serum/urine osmolality and urine Na⁺; 3% NaCl boluses and DDAVP use; correction targets and monitoring plan.
- Encephalopathy due to hyponatremia, {acute/chronic}; objective neuro findings (seizure, GCS); imaging/labs supporting diagnosis; treatment and safety measures taken.
- Risk for osmotic demyelination: {alcoholism/malnutrition/liver disease/hypokalemia}; stated **Na⁺ correction limits** and frequency of monitoring.
- Dialysis candidacy/consultation if refractory hyperkalemia; indication documented (persistent **K⁺ ≥6.5**, ECG changes, failure of medical therapy). citeturn2search19turn2search38
